EUVIMEDEUVIMED entdecken
Crossref

Quantifying Transporter Activity: An Absolute Scaling Approach Using Digoxin

Maïlys De Sousa Mendes iD, Venkatesh Pilla-Reddy, Hong Shen, Darren M Moss, Hélène Chapy, Birk Poller, Masanori Nakakariya, Oliver Poetz iD, Helen Sophie Hammer iD, Alice Tsai, Buyun Chen, Csilla Temesszentandrási-Ambrus iD und 2 weitere

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Maïlys De Sousa Mendes und 13 weiteren Autor:innen. Beteiligte Einrichtung: Certara UK Ltd (Certara Predictive Technologies), Sheffield S1 2BJ, U.K. Hauptthemen laut MEDLINE: Digoxin, ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lilly Laboratories porcine kidney 1 (LLC-PK1) and Madin-Darby canine kidney (MDCK) cell lines are commonly used in studying both passive and active drug transport, particularly through permeation assays, and, when transfected with human MDR1, to assess P-glycoprotein (P-gp)-mediated drug clearance. However, the substantial variability in experimental outcomes, including P-gp activity, presents a significant challenge to drug development and transporter research. In this study, P-gp protein expression levels were quantified in 8 cell lines used across different laboratories to evaluate digoxin transfer in a Transwell assay. P-gp activity was estimated using both conventional analysis methods and an in vitro modeling approach. Parameters derived from conventional methods, such as apparent permeability (Papp) and Michaelis-Menten parameters (Km,app and Jmax), exhibited notable interlaboratory variability and could increase the risk of underestimating the impact of transporters and their saturation when used in a physiologically based pharmacokinetic (PBPK) model. By contrast, modeling-based estimates of P-gp activity demonstrated a strong correlation with absolute transporter abundance in the cell lines. This expression-function relationship supports the accurate scaling of the P-gp activity across tissues based on expression levels. A PBPK model for digoxin was developed incorporating P-gp activity in key organs, scaled according to measured expression. These findings underscore the importance of quantifying transporter expression in in vitro systems and integrating this information into a modeling framework to enable reliable in vitro-to-in vivo extrapolation (IVIVE).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DigoxinATP Binding Cassette Transporter, Subfamily B, Member 1AnimalsDogsMadin Darby Canine Kidney CellsHumansSwineBiological TransportLLC-PK1 CellsATP Binding Cassette Transporter, Subfamily BCell LineModels, Biological

Stichwörter der Autor:innen

IVIVE-PBPKP-gpSimcypTranswellabsolute abundancedigoxintransporter

Substanzen

DigoxinATP Binding Cassette Transporter, Subfamily B, Member 1ATP Binding Cassette Transporter, Subfamily B

Autor:innen und Institutionen

  • Certara UK Ltd (Certara Predictive Technologies), Sheffield S1 2BJ, U.K.
  • Eli Lilly and Company Limited, Global PK/PD & Pharmacometrics, Bracknell RG12 1PU, U.K.
  • Bristol Myers Squibb, Princeton, New Jersey 08648, United States.
  • Johnson & Johnson, Preclinical Sciences & Translational Safety, Beerse 2340, Belgium.
  • UCB, Braine l'Alleud 1420, Belgium.
  • Novartis Pharma AG, Basel 4056, Switzerland.

ORCID-Profile: Maïlys De Sousa Mendes, Oliver Poetz, Helen Sophie Hammer, Csilla Temesszentandrási-Ambrus, Jacek R Wisniewski, Sibylle Neuhoff

Zitieren

APA

De Sousa Mendes, M., Pilla-Reddy, V., Shen, H., Moss, D. M., Chapy, H., Poller, B., Nakakariya, M., Poetz, O., Hammer, H. S., Tsai, A., Chen, B., Temesszentandrási-Ambrus, C., Wisniewski, J. R., & Neuhoff, S. (2026). Quantifying Transporter Activity: An Absolute Scaling Approach Using Digoxin. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01878

Vancouver

De Sousa Mendes M, Pilla-Reddy V, Shen H, Moss DM, Chapy H, Poller B, et al. Quantifying Transporter Activity: An Absolute Scaling Approach Using Digoxin. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01878

BibTeX
@article{DeSousaMendes2026,
  author = {De Sousa Mendes, Maïlys and Pilla-Reddy, Venkatesh and Shen, Hong and Moss, Darren M and Chapy, Hélène and Poller, Birk and Nakakariya, Masanori and Poetz, Oliver and Hammer, Helen Sophie and Tsai, Alice and Chen, Buyun and Temesszentandrási-Ambrus, Csilla and Wisniewski, Jacek R and Neuhoff, Sibylle},
  title = {Quantifying Transporter Activity: An Absolute Scaling Approach Using Digoxin},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01878}
}
Kostenlos starten →